On the webinar yesterday Steve mentioned that with the recent cost cutting and forecast sales, they are expecting breakeven around the December quarter this year. With iHerb and CVS coming on board, as well as potentially other retailers, there is potential for EBITDA in the millions for 2024.
The question is what EBITA multiple will NGS trade on once profitable?
- Forums
- ASX - By Stock
- NGS
- Ann: Update on North American Expansion Strategy
Ann: Update on North American Expansion Strategy, page-12
Featured News
Add NGS (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.255M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $3K | 1M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10590967 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 3797879 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 10590967 | 0.003 |
10 | 9689611 | 0.002 |
6 | 14400999 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 3797879 | 8 |
0.005 | 3045000 | 6 |
0.006 | 10489998 | 7 |
0.007 | 30000 | 1 |
0.009 | 30000 | 1 |
Last trade - 10.06am 23/07/2024 (20 minute delay) ? |
Featured News
NGS (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online